Back to Results
First PageMeta Content
Treatment of bipolar disorder / Neurotechnology / Electroconvulsive therapy / Year of birth missing / Mental health / Linda Andre / Food and Drug Administration / Major depressive disorder / Premarket approval / Medicine / Psychiatry / Health


To: Dockets ManagementBranch Food and Drug Administration 5630 Fishers Lane (Room[removed]Rockville, MD[removed]The Committee for Truth in Psychiatry submits this petition pursuant to 21 CFR
Add to Reading List

Document Date: 2004-01-20 17:25:16

Open Document

File Size: 925,70 KB

Share Result on Facebook

City

Rockville / Graz / London / New York / West Yorks / /

Company

Springer Publishing Co. / Hartlage LC / Donahue AB / GE / /

Country

Austria / United Kingdom / /

Currency

pence / /

Facility

The Cochrane Library / Institute of Psychiatry / /

IndustryTerm

electroconvulsive theranv device / imaging / /

MedicalCondition

brain damageand memory loss / memory dysfunction / schizophrenia / cognitive dysfunction / injury / New Evidencefor Permanent Memory Loss / depressionand amnesia / memory loss / depression / Chronic / treatment-resistant depressionand / /

MedicalTreatment

electroconvulsive therapy / /

OperatingSystem

Genera / /

Organization

American Psychiatric Association / Institute of Psychiatry / Food and Drug Administration / Class HI1 Committee / Committee for Truth / /

Person

Lewis A. She / Nathan N. Morbidity / Linda Andre / Taylor JR / /

Position

Director / Director of the Comrnittee / requestthe Commissioner / /

ProvinceOrState

Maryland / New York / /

PublishedMedium

British Journal of Psychiatry / British Medical Journal / The American Journal / /

SocialTag